VerifiedBiotechnology Research

Epibiologics

EpiBiologics is advancing bispecific antibodies that selectively degrade membrane and soluble proteins, including GPCRs. Our EpiTAC platform leverages a novel atlas of tissue-selective degrader receptors to drive deep and durable efficacy. The company was founded in 2022 based on pioneering work from Dr. Jim Wells at UCSF. Headquartered in the SF Bay Area, EpiBiologics is backed by leading healthcare investors and building a clinical stage pipeline for oncology and immunology. For more information, please visit epibiologics.com and follow us on LinkedIn.

7-day free trial · no credit card

San Mateo, United States47(11 to 50)epibiologics.com LinkedIn

Verified contacts

35

available on Kipplo

LinkedIn employees

47

11 to 50 range

Open roles

—

no listings

Distinct roles

21

indexed titles

Tech stack

0

tools in use

Monthly traffic

21

organic / mo

Sign up free to see all 35 verified contacts at Epibiologics

Free for 7 days · 50 credits · no card · only pay for verified records.

Decision-makers and verified team members

35 contacts with verified email or phone · masked until revealed.

Sign up free →

Showing 9 of 35 verified contacts

Top roles at Epibiologics

21 distinct titles indexed · top 10 shown.

4scientist
2research associate ii
1- ä
1associate scientist
1board member
1ceo, president, and board member
1chief operating officer
1chief scientific officer
1co-founding scientist
1corcept therapeutics
+11more titles

Sign up to unlock all 35 contacts at Epibiologics

Free for 7 days · 50 credits · no card · only pay for verified records.

Sign up to reveal 35 verified contacts at Epibiologics

7-day trial · no credit card · cancel anytime · only pay for verified records.

Sign up free See pricing

Trusted by sales, marketing, and GTM engineering teams.

Epibiologics | Kipplo Discover